These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9312186)

  • 1. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
    De Franceschi L; Bachir D; Galacteros F; Tchernia G; Cynober T; Alper S; Platt O; Beuzard Y; Brugnara C
    J Clin Invest; 1997 Oct; 100(7):1847-52. PubMed ID: 9312186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse.
    De Franceschi L; Beuzard Y; Jouault H; Brugnara C
    Blood; 1996 Oct; 88(7):2738-44. PubMed ID: 8839870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia.
    De Franceschi L; Cappellini MD; Graziadei G; Manzato F; Olivieri O; Corrocher R; Fiorelli G; Beuzard Y; Brugnara C
    Haematologica; 1998 Feb; 83(2):118-25. PubMed ID: 9549922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):927-33. PubMed ID: 14663274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C
    Curr Opin Hematol; 1995 Mar; 2(2):132-8. PubMed ID: 9371983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane transport of Na and K and cell dehydration in sickle erythrocytes.
    Brugnara C
    Experientia; 1993 Feb; 49(2):100-9. PubMed ID: 8440348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
    De Franceschi L; Bachir D; Galacteros F; Tchernia G; Cynober T; Neuberg D; Beuzard Y; Brugnara C
    Br J Haematol; 2000 Feb; 108(2):284-9. PubMed ID: 10691856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydration of sickle cells using the sodium ionophore Monensin. A model for therapy.
    Clark MR; Mohandas N; Shohet SB
    J Clin Invest; 1982 Nov; 70(5):1074-80. PubMed ID: 7130394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C
    Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo.
    Ballas SK; Dover GJ; Charache S
    Am J Hematol; 1989 Oct; 32(2):104-11. PubMed ID: 2757007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide and its congeners on sickle red blood cell deformability.
    Belanger AM; Keggi C; Kanias T; Gladwin MT; Kim-Shapiro DB
    Transfusion; 2015 Oct; 55(10):2464-72. PubMed ID: 25912054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
    J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydration of sickle erythrocytes using a herbal extract (Pfaffia paniculata) in vitro.
    Ballas SK
    Br J Haematol; 2000 Oct; 111(1):359-62. PubMed ID: 11091225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia.
    Bookchin RM; Ortiz OE; Lew VL
    J Clin Invest; 1991 Jan; 87(1):113-24. PubMed ID: 1702096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.
    Hankins JS; Wynn LW; Brugnara C; Hillery CA; Li CS; Wang WC
    Br J Haematol; 2008 Jan; 140(1):80-5. PubMed ID: 17991298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell dehydration: Pathophysiology and therapeutic applications.
    Brugnara C
    Clin Hemorheol Microcirc; 2018; 68(2-3):187-204. PubMed ID: 29614632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.